Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy
- 1 May 2002
- journal article
- review article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 2 (5), 281-292
- https://doi.org/10.1016/s1473-3099(02)00263-3
Abstract
No abstract availableKeywords
This publication has 119 references indexed in Scilit:
- Human chorionic gonadotropin in the treatment of HIV-related Kaposi’s sarcomaEuropean Journal Of Cancer, 1998
- Sexual Transmission and the Natural History of Human Herpesvirus 8 InfectionNew England Journal of Medicine, 1998
- Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's SarcomaThe Journal of Clinical Pharmacology, 1996
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome: A clinical trial to evaluate efficacy and discomfort associated with injectionJournal of the American Academy of Dermatology, 1993
- Evaluation of different staging systems for Kaposi's sarcoma in HIV-infected patientsZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcomaJournal of the American Academy of Dermatology, 1990
- Prevalence of Kaposi's Sarcoma among Patients with AIDSNew England Journal of Medicine, 1985
- Kaposi's sarcoma in homosexual men: An immunohistochemical studyJournal of the American Academy of Dermatology, 1983